These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22202200)

  • 21. Synthesis and in vitro anticancer evaluation of some novel hexahydroquinoline derivatives having a benzenesulfonamide moiety.
    Al-Said MS; Ghorab MM; Al-Dosari MS; Hamed MM
    Eur J Med Chem; 2011 Jan; 46(1):201-7. PubMed ID: 21112675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, anticancer activity and pharmacokinetic analysis of 1-[(substituted 2-alkoxyquinoxalin-3-yl)aminocarbonyl]-4-(hetero)arylpiperazine derivatives.
    Lee YB; Gong YD; Kim DJ; Ahn CH; Kong JY; Kang NS
    Bioorg Med Chem; 2012 Feb; 20(3):1303-9. PubMed ID: 22226981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial activity of sulfonamides containing 5-chloro-2-hydroxybenzaldehyde and 5-chloro-2-hydroxybenzoic acid scaffold.
    Krátký M; Vinšová J; Volková M; Buchta V; Trejtnar F; Stolaříková J
    Eur J Med Chem; 2012 Apr; 50():433-40. PubMed ID: 22365879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and anticancer activity evaluation of new 2-alkylcarbonyl and 2-benzoyl-3-trifluoromethyl-quinoxaline 1,4-di-N-oxide derivatives.
    Zarranz B; Jaso A; Aldana I; Monge A
    Bioorg Med Chem; 2004 Jul; 12(13):3711-21. PubMed ID: 15186857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovering some novel tetrahydroquinoline derivatives bearing the biologically active sulfonamide moiety as a new class of antitumor agents.
    Alqasoumi SI; Al-Taweel AM; Alafeefy AM; Ghorab MM; Noaman E
    Eur J Med Chem; 2010 May; 45(5):1849-53. PubMed ID: 20149941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and cytotoxic evaluation of substituted sulfonyl-N-hydroxyguanidine derivatives as potential antitumor agents.
    Chern JW; Leu YL; Wang SS; Jou R; Lee CF; Tsou PC; Hsu SC; Liaw YC; Lin HM
    J Med Chem; 1997 Jul; 40(14):2276-86. PubMed ID: 9216847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and antitumoral activity of novel 3-(2-substituted-1,3,4-oxadiazol-5-yl) and 3-(5-substituted-1,2,4-triazol-3-yl) beta-carboline derivatives.
    Formagio AS; Tonin LT; Foglio MA; Madjarof C; de Carvalho JE; da Costa WF; Cardoso FP; Sarragiotto MH
    Bioorg Med Chem; 2008 Nov; 16(22):9660-7. PubMed ID: 18951806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent.
    Noolvi MN; Patel HM; Bhardwaj V; Chauhan A
    Eur J Med Chem; 2011 Jun; 46(6):2327-46. PubMed ID: 21458891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of anti-microtubule N-(2-Arylindol-7-yl)benzenesulfonamide derivatives and their antitumor mechanisms.
    Chiou CT; Chen GS; Chen ML; Li H; Shi L; Huang XH; Dai WM; Chern JW
    ChemMedChem; 2010 Sep; 5(9):1489-97. PubMed ID: 20672297
    [No Abstract]   [Full Text] [Related]  

  • 30. New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxides.
    Amin KM; Ismail MM; Noaman E; Soliman DH; Ammar YA
    Bioorg Med Chem; 2006 Oct; 14(20):6917-23. PubMed ID: 16843668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and docking studies of some novel quinoline derivatives bearing a sulfonamide moiety as possible anticancer agents.
    Ghorab MM; Ragab FA; Hamed MM
    Arzneimittelforschung; 2010; 60(3):141-8. PubMed ID: 20422946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of N-(7-indazolyl)benzenesulfonamide derivatives as potent cell cycle inhibitors.
    Bouissane L; El Kazzouli S; Léonce S; Pfeiffer B; Rakib EM; Khouili M; Guillaumet G
    Bioorg Med Chem; 2006 Feb; 14(4):1078-88. PubMed ID: 16274996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, anti-HIV-1 integrase, and cytotoxic activities of 4-chloro-N-(4-oxopyrimidin-2-yl)-2-mercaptobenzenesulfonamide derivatives.
    Brzozowski Z; Sławiński J; Saczewski F; Sanchez T; Neamati N
    Eur J Med Chem; 2008 Jun; 43(6):1188-98. PubMed ID: 17949860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and in vitro antitumor activity of novel series 2-benzylthio-4-chlorobenzenesulfonamide derivatives.
    Sławiński J; Brzozowski Z
    Eur J Med Chem; 2006 Oct; 41(10):1180-9. PubMed ID: 16777268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro.
    Bazargan L; Fouladdel S; Shafiee A; Amini M; Ghaffari SM; Azizi E
    Cell Biol Toxicol; 2008 Apr; 24(2):165-74. PubMed ID: 17805981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, structural characterization, and in vitro antitumor activity of novel N-(6-chloro-1,1-dioxo-1,4,2-benzodithiazin-3-yl)arylsulfonamides.
    Brzozowski Z; Saczewski F; Sławiński J; Bednarski PJ; Grünert R; Gdaniec M
    Bioorg Med Chem; 2007 Apr; 15(7):2560-72. PubMed ID: 17306551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors.
    Lu X; Zhang H; Li X; Chen G; Li QS; Luo Y; Ruan BF; Chen XW; Zhu HL
    Bioorg Med Chem; 2011 Nov; 19(22):6827-32. PubMed ID: 22000948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological evaluation of novel pyrazoles and pyrazolo[3,4-d]pyrimidines incorporating a benzenesulfonamide moiety.
    Ashour HM; Wahab AE
    Arch Pharm (Weinheim); 2009 Apr; 342(4):238-52. PubMed ID: 19340837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of 4-(5,5-dimethyl-3-oxo-cyclohex-1-enylamino)benzenesulfonamide in the synthesis of novel quinolines as possible anticancer and radioprotective agents.
    Ghorab MM; Ragab FA; Noaman E; Heiba HI; El-Hossary EM
    Arzneimittelforschung; 2008; 58(1):35-41. PubMed ID: 18368949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and in vitro antitumor activity of new quinoxaline derivatives.
    Corona P; Carta A; Loriga M; Vitale G; Paglietti G
    Eur J Med Chem; 2009 Apr; 44(4):1579-91. PubMed ID: 18774202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.